Cobalt's Generic Boniva Barred In Roche IP Spat
A federal judge on Wednesday granted Hoffman-La Roche Ltd.'s bid for a preliminary injunction to bar Cobalt Pharmaceuticals Inc. from launching a generic version of bone-loss prevention treatment Boniva....To view the full article, register now.
Already a subscriber? Click here to view full article